| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.28▼ | 3.38▼ | 3.39▼ | 3.45▼ | 3.74▼ |
| MA10 | 3.34▼ | 3.41▼ | 3.42▼ | 3.61▼ | 2.41▲ |
| MA20 | 3.37▼ | 3.43▼ | 3.42▼ | 4.17▼ | 1.78▲ |
| MA50 | 3.42▼ | 3.43▼ | 3.55▼ | 2.34▲ | 1.41▲ |
| MA100 | 3.42▼ | 3.55▼ | 3.92▼ | 1.74▲ | 1.45▲ |
| MA200 | 3.44▼ | 4.06▼ | 3.23▲ | 1.45▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.015▼ | -0.012▼ | -0.001▼ | -0.213▼ | 0.289▲ |
| RSI | 33.454▼ | 36.783▼ | 36.135▼ | 49.340▼ | 64.185▲ |
| STOCH | 21.149 | 30.375 | 38.095 | 13.111▼ | 53.890 |
| WILL %R | -72.093 | -78.571▼ | -85.714▼ | -92.308▼ | -61.590 |
| CCI | -96.921 | -284.470▼ | -265.570▼ | -97.221 | 73.057 |
|
Tuesday, March 31, 2026 05:54 AM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announced the initiation ...
|
|
Friday, March 27, 2026 06:00 AM
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
|
|
Monday, March 16, 2026 04:59 PM
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/04/26 | 3.45 | 3.536 | 3.11 | 3.27 | 412,080 |
| 01/04/26 | 3.49 | 3.6761 | 3.29 | 3.45 | 390,178 |
| 31/03/26 | 3.51 | 3.53 | 3.295 | 3.42 | 238,394 |
| 30/03/26 | 3.57 | 3.705 | 3.28 | 3.46 | 254,887 |
| 27/03/26 | 3.66 | 4.01 | 3.56 | 3.66 | 264,346 |
| 26/03/26 | 3.66 | 3.9123 | 3.45 | 3.61 | 321,536 |
| 25/03/26 | 3.83 | 4.015 | 3.47 | 3.66 | 633,736 |
| 24/03/26 | 3.77 | 3.82 | 3.44 | 3.77 | 451,924 |
| 23/03/26 | 3.87 | 3.9689 | 3.64 | 3.83 | 344,941 |
| 20/03/26 | 3.76 | 4.25 | 3.76 | 4.00 | 267,435 |
|
|
||||
|
|
||||
|
|